Compare DGII & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DGII | INVA |
|---|---|---|
| Founded | 1985 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | N/A | 2004 |
| Metric | DGII | INVA |
|---|---|---|
| Price | $42.52 | $19.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $48.80 | $36.80 |
| AVG Volume (30 Days) | 300.2K | ★ 940.8K |
| Earning Date | 02-04-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.05 | 53.96 |
| EPS | 1.08 | ★ 1.52 |
| Revenue | ★ $430,221,000.00 | $388,521,000.00 |
| Revenue This Year | $10.51 | $13.23 |
| Revenue Next Year | $8.01 | $8.58 |
| P/E Ratio | $39.67 | ★ $12.81 |
| Revenue Growth | 1.46 | ★ 10.14 |
| 52 Week Low | $22.39 | $16.52 |
| 52 Week High | $48.00 | $22.76 |
| Indicator | DGII | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 45.36 | 45.80 |
| Support Level | $42.48 | $19.26 |
| Resistance Level | $45.13 | $20.23 |
| Average True Range (ATR) | 1.21 | 0.46 |
| MACD | -0.39 | -0.03 |
| Stochastic Oscillator | 8.14 | 53.47 |
Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.